Medicare Enrolled

Dr. Arthi Kumaravel, M.D.

Gastroenterology · Fort Worth, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
900 W MAGNOLIA AVE, Fort Worth, TX 76104
8178707300
In practice since 2008 (18 years)
NPI: 1639348469 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kumaravel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kumaravel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kumaravel

Dr. Arthi Kumaravel is a gastroenterology in Fort Worth, TX, with 18 years in practice. Based on federal Medicare data, Dr. Kumaravel performed 4,585 Medicare services across 652 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kumaravel received a total of $10,095 from 50 pharmaceutical and/or device companies across 531 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kumaravel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 2% volume in TX$ $10,095 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,585
Medicare services
Top 2% in TX for gastroenterology
652
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~255 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Vedolizumab infusion (Entyvio)3,900$17$68
Office visit, established patient (30-39 min)86$86$217
Upper GI endoscopy with biopsy70$38$680
Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope65$153$955
Removal of polyps or growths of large bowel using an endoscope with mechanical snare57$197$1,067
Office visit, established patient (20-29 min)56$59$148
New patient office visit (45-59 min)48$113$334
Colonoscopy with biopsy36$112$847
Initial hospital admission, moderate complexity36$101$278
Hospital follow-up visit, moderate complexity34$62$146
Insertion of guide wire with dilation of esophagus using a flexible endoscope30$91$701
Review by radiologist of image from tube placement into bile duct using an endoscope28$18$146
New patient office or other outpatient visit, 15-29 minutes27$38$151
Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope25$174$1,110
Office visit, established patient (10-19 min)22$37$100
New patient office visit (30-44 min)15$85$219
Colorectal cancer screening; colonoscopy on individual at high risk14$165$778
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less13$50$146
Insertion of stent into pancreatic or bile duct using a flexible endoscope12$355$1,955
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope11$65$518
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
85.6% high complexity
4.6% medium
9.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,095
Total received (2018-2024)
Avg $1,442/year across 7 years
Top 20% in TX for gastroenterology
50
Companies
531
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,081 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,672
2023
$2,114
2022
$1,829
2021
$908
2020
$278
2019
$1,171
2018
$1,123

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,543
Boston Scientific Corporation
$1,482
Janssen Biotech, Inc.
$1,269
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$668
AbbVie, Inc.
$601
Takeda Pharmaceuticals U.S.A., Inc.
$592
PFIZER INC.
$333
Celgene Corporation
$319
Ferring Pharmaceuticals Inc.
$240
Daiichi Sankyo Inc.
$231
Novo Nordisk Inc
$227
AbbVie Inc.
$222
Regeneron Healthcare Solutions, Inc.
$212
QOL Medical, LLC
$201
Ethicon US, LLC
$179
Ironwood Pharmaceuticals, Inc
$173
VIVUS LLC
$139
RedHill Biopharma Inc.
$131
Organon LLC
$123
Ardelyx, Inc.
$96
Janssen Scientific Affairs, LLC
$86
Amgen Inc.
$85
Lilly USA, LLC
$84
Intercept Pharmaceuticals, Inc.
$79
Allergan Inc.
$72
Shionogi Inc
$69
Merck Sharp & Dohme LLC
$69
Madrigal Pharmaceuticals
$44
Braintree Laboratories, Inc.
$43
E.R. Squibb & Sons, L.L.C.
$42
INTERCEPT PHARMACEUTICALS, INC.
$41
Fresenius Kabi USA, LLC
$38
Merck Sharp & Dohme Corporation
$34
Nestle HealthCare Nutrition Inc.
$31
IRONWOOD PHARMACEUTICALS, INC
$30
UCB, Inc.
$28
Concordia Pharmaceuticals Inc.
$24
Enterra Medical, Inc.
$23
Romark Laboratories, LC
$21
AMAG Pharmaceuticals, Inc.
$21
BOSTON SCIENTIFIC CORPORATION
$17
Gilead Sciences, Inc.
$16
NESTLE HEALTHCARE NUTRITION INC.
$16
Organon Llc
$15
AstraZeneca Pharmaceuticals LP
$15
Phathom Pharmaceuticals, Inc.
$15
Celltrion USA Inc.
$14
Micro-tech Endoscopy USA, Inc.
$14
Cumberland Pharmaceuticals, Inc.
$13
Napo Pharmaceuticals Inc
$12
Top 3 companies account for 42.5% of total payments
Associated products mentioned in payments ›
APOLLO ESG System · AVSOLA · Alinia Tablets 500mg 30 count bottle · CLENPIQ · CRE PRO · CREON · Cimzia · Compliance EndoKit · Creon · DAT Closure Device · DIFICID · DONNATAL · DUPIXENT · ENTYVIO · EOHILIA · EXALT Model D · Entyvio · Epclusa · FERAHEME · GATTEX · General - Therapies · HADLIMA · HUMIRA · Humira · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · LINX Reflux Management System · LINZESS · Linzess · MOVANTIK · Mavyret · Movantik · Mulpleta · Mytesi · OCALIVA · OMVOH · Omeclamox · PANCREAZE · PRALUENT ALIROCUMAB INJECTION · QSYMIA · Qsymia · REBYOTA · RELISTOR · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · SPYGLASS · STELARA · SUCRAID · SUFLAVE · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · Trintellix · UCERIS TABLETS · VELSIPITY · VIBERZI · VOQUEZNA · Viekira · WallFlex Duodenal · Wegovy · XELJANZ · XIFAXAN · XIFAXANIBSD · YUFLYMA · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $220 per 100 Medicare services performed
Looking for a gastroenterology in Fort Worth?
Compare gastroenterologys in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
124
Per 100K population
5.8
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kumaravel is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 20%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kumaravel experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Kumaravel performed 3,900 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kumaravel receive payments from pharmaceutical companies?
Yes. Dr. Kumaravel received a total of $10,095 from 50 companies across 531 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kumaravel's costs compare to other gastroenterologys in Fort Worth?
Dr. Kumaravel's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kumaravel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →